Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Silverberg

Showing results (21-30 of 228) with videos related to

Pageof 23
Sort By:
Inflammatory Bowel Diseases|March 15, 2008
Population-based case-control study of alpha 1-antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitisRoman Kotlowski, Charles N Bernstein, Mark S Silverberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's diseaseElana A Maser, Renata Villela, Mark S Silverberg, et al.
Inflammatory Bowel Diseases|February 21, 2002
Risk factors for low bone density in Crohn's diseaseAida Habtezion, Mark S Silverberg, Robert Parkes, et al.
Gastroenterology|January 7, 2022
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?Bram Verstockt, Brian Bressler, Helena Martinez-Lozano, et al.
Inflammatory Bowel Diseases|May 31, 2014
Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitisBoyko Kabakchiev, Andrea Tyler, Joanne M Stempak, et al.
F1000Prime Reports|September 4, 2014
Microbiome analysis - from technical advances to biological relevanceMichelle I Smith, Williams Turpin, Andrea D Tyler, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Inflammatory Bowel Diseases|December 29, 2019
Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative ColitisDavid Kevans, Richard Kirsch, Callum Dargavel, et al.
Journal of Crohn'S & Colitis|April 19, 2014
Future directions in inflammatory bowel disease managementGeert R D'Haens, R Balfour Sartor, Mark S Silverberg, et al.
Journal of Crohn'S & Colitis|April 20, 2019
Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy SubjectsAylia Mohammadi, Orlaith B Kelly, Michelle I Smith, et al.
Pageof 23

Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Inflammatory Bowel Diseases|March 15, 2008
Population-based case-control study of alpha 1-antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitisRoman Kotlowski, Charles N Bernstein, Mark S Silverberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's diseaseElana A Maser, Renata Villela, Mark S Silverberg, et al.
Inflammatory Bowel Diseases|February 21, 2002
Risk factors for low bone density in Crohn's diseaseAida Habtezion, Mark S Silverberg, Robert Parkes, et al.
Gastroenterology|January 7, 2022
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?Bram Verstockt, Brian Bressler, Helena Martinez-Lozano, et al.
Inflammatory Bowel Diseases|May 31, 2014
Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitisBoyko Kabakchiev, Andrea Tyler, Joanne M Stempak, et al.
F1000Prime Reports|September 4, 2014
Microbiome analysis - from technical advances to biological relevanceMichelle I Smith, Williams Turpin, Andrea D Tyler, et al.
Journal of Crohn'S & Colitis|April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Inflammatory Bowel Diseases|December 29, 2019
Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative ColitisDavid Kevans, Richard Kirsch, Callum Dargavel, et al.
Journal of Crohn'S & Colitis|April 19, 2014
Future directions in inflammatory bowel disease managementGeert R D'Haens, R Balfour Sartor, Mark S Silverberg, et al.
Journal of Crohn'S & Colitis|April 20, 2019
Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy SubjectsAylia Mohammadi, Orlaith B Kelly, Michelle I Smith, et al.
Pageof 23